Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems.

Grillo A, Chemi G, Brogi S, Brindisi M, Relitti N, Fezza F, Fazio D, Castelletti L, Perdona E, Wong A, Lamponi S, Pecorelli A, Benedusi M, Fantacci M, Valoti M, Valacchi G, Micheli F, Novellino E, Campiani G, Butini S, Maccarrone M, Gemma S.

Eur J Med Chem. 2019 Sep 4;183:111674. doi: 10.1016/j.ejmech.2019.111674. [Epub ahead of print]

PMID:
31518969
2.

An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction.

Sirous H, Chemi G, Campiani G, Brogi S.

Comput Biol Chem. 2019 Aug 16;83:107105. doi: 10.1016/j.compbiolchem.2019.107105. [Epub ahead of print]

PMID:
31473433
3.

Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach.

Sirous H, Chemi G, Gemma S, Butini S, Debyser Z, Christ F, Saghaie L, Brogi S, Fassihi A, Campiani G, Brindisi M.

Front Chem. 2019 Aug 13;7:574. doi: 10.3389/fchem.2019.00574. eCollection 2019.

4.

Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.

Brindisi M, Saraswati AP, Brogi S, Gemma S, Butini S, Campiani G.

J Med Chem. 2019 Aug 27. doi: 10.1021/acs.jmedchem.9b00924. [Epub ahead of print]

PMID:
31415174
5.

Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II).

D'Alessandro S, Alfano G, Di Cerbo L, Brogi S, Chemi G, Relitti N, Brindisi M, Lamponi S, Novellino E, Campiani G, Gemma S, Basilico N, Taramelli D, Baratto MC, Pogni R, Butini S.

Bioorg Chem. 2019 Aug;89:103020. doi: 10.1016/j.bioorg.2019.103020. Epub 2019 May 31.

PMID:
31185392
6.

Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.

Saraswati AP, Relitti N, Brindisi M, Gemma S, Zisterer D, Butini S, Campiani G.

Drug Discov Today. 2019 Jul;24(7):1370-1388. doi: 10.1016/j.drudis.2019.05.015. Epub 2019 May 25. Review.

PMID:
31136800
7.

Dietary polyphenols rutin, taxifolin and quercetin related compounds target Leishmania amazonensis arginase.

da Silva ER, Brogi S, Lucon-Júnior JF, Campiani G, Gemma S, Maquiaveli CDC.

Food Funct. 2019 Jun 19;10(6):3172-3180. doi: 10.1039/c9fo00265k.

PMID:
31134235
8.

A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision.

Chemi G, Brindisi M, Brogi S, Relitti N, Butini S, Gemma S, Campiani G.

Future Med Chem. 2019 Mar;11(5):463-487. doi: 10.4155/fmc-2018-0315. Epub 2019 Mar 25.

PMID:
30907134
9.

Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders.

Brogi S, Campiani G, Brindisi M, Butini S.

ACS Med Chem Lett. 2019 Jan 23;10(3):228-236. doi: 10.1021/acsmedchemlett.8b00450. eCollection 2019 Mar 14.

PMID:
30891118
10.

Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors.

Sirous H, Fassihi A, Brogi S, Campiani G, Christ F, Debyser Z, Gemma S, Butini S, Chemi G, Grillo A, Zabihollahi R, Aghasadeghi MR, Saghaie L, Memarian HR.

Med Chem. 2018 Dec 18. doi: 10.2174/1573406415666181219113225. [Epub ahead of print]

PMID:
30569867
11.

Author Correction: The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity.

Colangeli R, Pierucci M, Benigno A, Campiani G, Butini S, Di Giovanni G.

Sci Rep. 2018 Dec 14;8(1):17977. doi: 10.1038/s41598-018-37392-y.

12.

Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents.

Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asís Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE, Olieric N, Lucena-Agell D, Barasoain I, Diaz JF, Nebbioso A, Conte M, Lopresti L, Magnano S, Amet R, Kinsella P, Zisterer DM, Ibrahim O, O'Sullivan J, Morbidelli L, Spaccapelo R, Baldari C, Butini S, Novellino E, Campiani G, Altucci L, Steinmetz MO, Brogi S.

Eur J Med Chem. 2019 Jan 15;162:290-320. doi: 10.1016/j.ejmech.2018.11.004. Epub 2018 Nov 3.

PMID:
30448418
13.

Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase.

da Silva ER, Brogi S, Grillo A, Campiani G, Gemma S, Vieira PC, Maquiaveli CDC.

Chem Biol Drug Des. 2019 Feb;93(2):139-146. doi: 10.1111/cbdd.13391. Epub 2018 Oct 10.

PMID:
30216691
14.

Development of a Multiplexed Activity-Based Protein Profiling Assay to Evaluate Activity of Endocannabinoid Hydrolase Inhibitors.

Janssen APA, van der Vliet D, Bakker AT, Jiang M, Grimm SH, Campiani G, Butini S, van der Stelt M.

ACS Chem Biol. 2018 Sep 21;13(9):2406-2413. doi: 10.1021/acschembio.8b00534. Epub 2018 Sep 12.

15.

Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies.

Brindisi M, Senger J, Cavella C, Grillo A, Chemi G, Gemma S, Cucinella DM, Lamponi S, Sarno F, Iside C, Nebbioso A, Novellino E, Shaik TB, Romier C, Herp D, Jung M, Butini S, Campiani G, Altucci L, Brogi S.

Eur J Med Chem. 2018 Sep 5;157:127-138. doi: 10.1016/j.ejmech.2018.07.069. Epub 2018 Jul 31.

PMID:
30092367
16.

Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain.

Brindisi M, Borrelli G, Brogi S, Grillo A, Maramai S, Paolino M, Benedusi M, Pecorelli A, Valacchi G, Di Cesare Mannelli L, Ghelardini C, Allarà M, Ligresti A, Minetti P, Campiani G, di Marzo V, Butini S, Gemma S.

ChemMedChem. 2018 Oct 8;13(19):2090-2103. doi: 10.1002/cmdc.201800397. Epub 2018 Aug 30.

PMID:
30085402
17.

iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome.

Landucci E, Brindisi M, Bianciardi L, Catania LM, Daga S, Croci S, Frullanti E, Fallerini C, Butini S, Brogi S, Furini S, Melani R, Molinaro A, Lorenzetti FC, Imperatore V, Amabile S, Mariani J, Mari F, Ariani F, Pizzorusso T, Pinto AM, Vaccarino FM, Renieri A, Campiani G, Meloni I.

Exp Cell Res. 2018 Jul 15;368(2):225-235. doi: 10.1016/j.yexcr.2018.05.001. Epub 2018 May 4.

PMID:
29730163
18.

Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.

Vallone A, D'Alessandro S, Brogi S, Brindisi M, Chemi G, Alfano G, Lamponi S, Lee SG, Jez JM, Koolen KJM, Dechering KJ, Saponara S, Fusi F, Gorelli B, Taramelli D, Parapini S, Caldelari R, Campiani G, Gemma S, Butini S.

Eur J Med Chem. 2018 Apr 25;150:698-718. doi: 10.1016/j.ejmech.2018.03.024. Epub 2018 Mar 10.

19.

Author Correction: The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity.

Colangeli R, Pierucci M, Benigno A, Campiani G, Butini S, Di Giovanni G.

Sci Rep. 2018 Mar 12;8(1):4648. doi: 10.1038/s41598-018-23084-0.

20.

( S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological Investigation.

Brogi S, Brindisi M, Butini S, Kshirsagar GU, Maramai S, Chemi G, Gemma S, Campiani G, Novellino E, Fiorenzani P, Pinassi J, Aloisi AM, Gynther M, Venskutonytė R, Han L, Frydenvang K, Kastrup JS, Pickering DS.

J Med Chem. 2018 Mar 8;61(5):2124-2130. doi: 10.1021/acs.jmedchem.8b00099. Epub 2018 Feb 26.

PMID:
29451794
21.

Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages.

Paolino M, Brindisi M, Vallone A, Butini S, Campiani G, Nannicini C, Giuliani G, Anzini M, Lamponi S, Giorgi G, Sbardella D, Ferraris DM, Marini S, Coletta M, Palucci I, Minerva M, Delogu G, Pepponi I, Goletti D, Cappelli A, Gemma S, Brogi S.

ChemMedChem. 2018 Mar 6;13(5):422-430. doi: 10.1002/cmdc.201700759. Epub 2018 Feb 14.

PMID:
29334428
22.

Activation of the Wnt Pathway by Small Peptides: Rational Design, Synthesis and Biological Evaluation.

Brogi S, Maramai S, Brindisi M, Chemi G, Porcari V, Corallo C, Gennari L, Novellino E, Ramunno A, Butini S, Campiani G, Gemma S.

ChemMedChem. 2017 Dec 19;12(24):2074-2085. doi: 10.1002/cmdc.201700551. Epub 2017 Nov 29.

PMID:
29131552
23.
24.

First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.

Brogi S, Ramunno A, Savi L, Chemi G, Alfano G, Pecorelli A, Pambianchi E, Galatello P, Compagnoni G, Focher F, Biamonti G, Valacchi G, Butini S, Gemma S, Campiani G, Brindisi M.

Eur J Med Chem. 2017 Sep 29;138:438-457. doi: 10.1016/j.ejmech.2017.06.017. Epub 2017 Jun 9.

PMID:
28689095
25.

Computational Tool for Fast in silico Evaluation of hERG K+ Channel Affinity.

Chemi G, Gemma S, Campiani G, Brogi S, Butini S, Brindisi M.

Front Chem. 2017 Feb 23;5:7. doi: 10.3389/fchem.2017.00007. eCollection 2017.

26.

Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX.

Brogi S, Fiorillo A, Chemi G, Butini S, Lalle M, Ilari A, Gemma S, Campiani G.

Eur J Med Chem. 2017 Jul 28;135:479-490. doi: 10.1016/j.ejmech.2017.04.057. Epub 2017 Apr 24.

PMID:
28477573
27.

Pre-clinical evaluation of a novel class of anti-cancer agents, the Pyrrolo-1, 5-benzoxazepines.

Greene LM, Butini S, Campiani G, Williams DC, Zisterer DM.

J Cancer. 2016 Dec 4;7(15):2367-2377. eCollection 2016. Review.

28.

Identification of novel fluorescent probes preventing PrPSc replication in prion diseases.

Zaccagnini L, Brogi S, Brindisi M, Gemma S, Chemi G, Legname G, Campiani G, Butini S.

Eur J Med Chem. 2017 Feb 15;127:859-873. doi: 10.1016/j.ejmech.2016.10.064. Epub 2016 Nov 1.

PMID:
27842893
29.

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.

Maramai S, Gemma S, Brogi S, Campiani G, Butini S, Stark H, Brindisi M.

Front Neurosci. 2016 Oct 5;10:451. eCollection 2016. Review.

30.

Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies.

Brindisi M, Cavella C, Brogi S, Nebbioso A, Senger J, Maramai S, Ciotta A, Iside C, Butini S, Lamponi S, Novellino E, Altucci L, Jung M, Campiani G, Gemma S.

Future Med Chem. 2016 Sep;8(13):1573-87. doi: 10.4155/fmc-2016-0068. Epub 2016 Aug 24.

PMID:
27556815
31.

Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine-induced apoptosis in neuroblastoma cells.

Lennon JC, Butini S, Campiani G, O'Meara A, Williams DC, Zisterer DM.

Invest New Drugs. 2016 Oct;34(5):663-76. doi: 10.1007/s10637-016-0366-3. Epub 2016 Jun 22.

PMID:
27334143
32.

Polypharmacology of dopamine receptor ligands.

Butini S, Nikolic K, Kassel S, Brückmann H, Filipic S, Agbaba D, Gemma S, Brogi S, Brindisi M, Campiani G, Stark H.

Prog Neurobiol. 2016 Jul;142:68-103. doi: 10.1016/j.pneurobio.2016.03.011. Epub 2016 May 24. Review.

PMID:
27234980
33.

The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.

Nathwani SM, Greene LM, Butini S, Campiani G, Williams DC, Samali A, Szegezdi E, Zisterer DM.

Int J Oncol. 2016 Jul;49(1):74-88. doi: 10.3892/ijo.2016.3518. Epub 2016 May 12.

34.

Development of novel cyclic peptides as pro-apoptotic agents.

Brindisi M, Maramai S, Brogi S, Fanigliulo E, Butini S, Guarino E, Casagni A, Lamponi S, Bonechi C, Nathwani SM, Finetti F, Ragonese F, Arcidiacono P, Campiglia P, Valenti S, Novellino E, Spaccapelo R, Morbidelli L, Zisterer DM, Williams CD, Donati A, Baldari C, Campiani G, Ulivieri C, Gemma S.

Eur J Med Chem. 2016 Jul 19;117:301-20. doi: 10.1016/j.ejmech.2016.04.001. Epub 2016 Apr 5.

PMID:
27150036
35.

Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.

Brindisi M, Brogi S, Giovani S, Gemma S, Lamponi S, De Luca F, Novellino E, Campiani G, Docquier JD, Butini S.

J Enzyme Inhib Med Chem. 2016;31(sup1):98-109. Epub 2016 Apr 28.

PMID:
27121013
36.

Verbascoside Inhibits Promastigote Growth and Arginase Activity of Leishmania amazonensis.

Maquiaveli CC, Lucon-Júnior JF, Brogi S, Campiani G, Gemma S, Vieira PC, Silva ER.

J Nat Prod. 2016 May 27;79(5):1459-63. doi: 10.1021/acs.jnatprod.5b00875. Epub 2016 Apr 20.

PMID:
27096224
37.

Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.

Brindisi M, Maramai S, Gemma S, Brogi S, Grillo A, Di Cesare Mannelli L, Gabellieri E, Lamponi S, Saponara S, Gorelli B, Tedesco D, Bonfiglio T, Landry C, Jung KM, Armirotti A, Luongo L, Ligresti A, Piscitelli F, Bertucci C, Dehouck MP, Campiani G, Maione S, Ghelardini C, Pittaluga A, Piomelli D, Di Marzo V, Butini S.

J Med Chem. 2016 Mar 24;59(6):2612-32. doi: 10.1021/acs.jmedchem.5b01812. Epub 2016 Mar 7.

38.

The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15.

Kinsella P, Greene LM, Bright SA, Pollock JK, Butini S, Campiani G, Bauer S, Williams DC, Zisterer DM.

Invest New Drugs. 2016 Apr;34(2):159-67. doi: 10.1007/s10637-016-0331-1. Epub 2016 Feb 17.

PMID:
26885657
39.

In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors.

Brogi S, Giovani S, Brindisi M, Gemma S, Novellino E, Campiani G, Blackman MJ, Butini S.

J Mol Graph Model. 2016 Mar;64:121-130. doi: 10.1016/j.jmgm.2016.01.005. Epub 2016 Jan 19.

40.

Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.

Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, Campiani G, Filipic S, Agbaba D, Esteban G, Unzeta M, Nikolic K, Butini S, Marco-Contelles J.

Prog Neurobiol. 2017 Apr;151:4-34. doi: 10.1016/j.pneurobio.2015.12.003. Epub 2016 Jan 18. Review.

PMID:
26797191
41.

Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation.

Wu MY, Esteban G, Brogi S, Shionoya M, Wang L, Campiani G, Unzeta M, Inokuchi T, Butini S, Marco-Contelles J.

Eur J Med Chem. 2016 Oct 4;121:864-879. doi: 10.1016/j.ejmech.2015.10.001. Epub 2015 Oct 9.

PMID:
26471320
42.

Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents.

Brogi S, Brindisi M, Joshi BP, Sanna Coccone S, Parapini S, Basilico N, Novellino E, Campiani G, Gemma S, Butini S.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5412-8. doi: 10.1016/j.bmcl.2015.09.007. Epub 2015 Sep 5.

PMID:
26428874
43.

Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.

Fiore D, Proto MC, Pisanti S, Picardi P, Pagano Zottola AC, Butini S, Gemma S, Casagni A, Laezza C, Vitale M, Ligresti A, Di Marzo V, Zisterer DM, Nathwani S, Williams DC, Campiani G, Gazzerro P, Bifulco M.

Cancer Biol Ther. 2016 Aug 2;17(8):849-58. doi: 10.1080/15384047.2015.1078028.

44.

Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats.

Lim J, Igarashi M, Jung KM, Butini S, Campiani G, Piomelli D.

Neuropsychopharmacology. 2016 Apr;41(5):1329-39. doi: 10.1038/npp.2015.284. Epub 2015 Sep 11.

45.

Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents.

Spallarossa A, Caneva C, Caviglia M, Alfei S, Butini S, Campiani G, Gemma S, Brindisi M, Zisterer DM, Bright SA, Williams CD, Crespan E, Maga G, Sanna G, Delogu I, Collu G, Loddo R.

Eur J Med Chem. 2015 Sep 18;102:648-60. doi: 10.1016/j.ejmech.2015.08.009. Epub 2015 Aug 8.

PMID:
26320088
46.

Site-directed Mutagenesis of Key Residues Unveiled a Novel Allosteric Site on Human Adenosine Kinase for Pyrrolobenzoxa(thia)zepinone Non-Nucleoside Inhibitors.

Savi L, Brindisi M, Alfano G, Butini S, La Pietra V, Novellino E, Marinelli L, Lossani A, Focher F, Cavella C, Campiani G, Gemma S.

Chem Biol Drug Des. 2016 Jan;87(1):112-20. doi: 10.1111/cbdd.12630. Epub 2015 Sep 18.

PMID:
26242695
47.

Induction of apoptosis in oral squamous carcinoma cells by pyrrolo-1,5-benzoxazepines.

O'Callaghan K, Palagano E, Butini S, Campiani G, Williams DC, Zisterer DM, O'Sullivan J.

Mol Med Rep. 2015 Sep;12(3):3748-3754. doi: 10.3892/mmr.2015.3832. Epub 2015 May 25.

PMID:
26005189
48.

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking.

Brindisi M, Brogi S, Relitti N, Vallone A, Butini S, Gemma S, Novellino E, Colotti G, Angiulli G, Di Chiaro F, Fiorillo A, Ilari A, Campiani G.

Sci Rep. 2015 May 7;5:9705. doi: 10.1038/srep09705.

49.

Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies.

Brindisi M, Butini S, Franceschini S, Brogi S, Trotta F, Ros S, Cagnotto A, Salmona M, Casagni A, Andreassi M, Saponara S, Gorelli B, Weikop P, Mikkelsen JD, Scheel-Kruger J, Sandager-Nielsen K, Novellino E, Campiani G, Gemma S.

J Med Chem. 2014 Nov 26;57(22):9578-97. doi: 10.1021/jm501119j. Epub 2014 Nov 7.

PMID:
25343529
50.

The web of clinical data.

Gori M, Campiani G, Rossi A, Setacci C.

J Cardiovasc Surg (Torino). 2014 Oct;55(5):717-8. No abstract available.

PMID:
25175948

Supplemental Content

Loading ...
Support Center